Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
104M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
4.8M
-
Shares change
-
+320K
-
Total reported value, excl. options
-
$21.9M
-
Value change
-
+$1.45M
-
Number of buys
-
9
-
Number of sells
-
-4
-
Price
-
$4.57
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q4 2016
19 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q4 2016.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.8M shares
of 104M outstanding shares and own 4.63% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3.07M shares), Southpoint Capital Advisors LP (800K shares), Knoll Capital Management, LP (462K shares), VANGUARD GROUP INC (203K shares), GEODE CAPITAL MANAGEMENT, LLC (101K shares), MORGAN STANLEY (59.9K shares), GARRISON BRADFORD & ASSOCIATES INC (15.5K shares), ROYAL BANK OF CANADA (14K shares), NORTHERN TRUST CORP (14K shares), and Creative Planning (13.5K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.